pharmaphorum June 4, 2020
A survey of clinical research professionals has found an acceleration in the adoption of virtual studies during the coronavirus pandemic.
The poll of 114 triallists by clinical data specialist ERT found that 82% of them said their organisations are using virtual trial approaches which minimise the need for physical contact between patients and staff, up from 33% prior to COVID-19.
That could include tablets and smartphones for patient monitoring and communication, apps, and wearable sensor devices, for example, as well as social media engagement. Using this approach screening, visits and data transmission are managed electronically from remote locations, notes ERT.
The finding isn’t wholly surprising given that government-imposed stay-at-home orders have made recruiting patients via traditional methods and the usual...
Today's Sponsors
Today's Sponsor